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Abstract CD28 costimulatory signal transduction in T
lymphocytes is essential for optimal telomerase activity,
stabilization of cytokine mRNAs, and glucose metabolism.
During aging and chronic infection with HIV-1, there are
increased proportions of CD8 T lymphocytes that lack
CD28 expression and show additional features of replica-
tive senescence. Moreover, the abundance of these cells
correlates with decreased vaccine responsiveness, early
mortality in the very old, and accelerated HIV disease
progression. Here, we show that sustained expression of
CD28, via gene transduction, retards the process
of replicative senescence, as evidenced by enhanced
telomerase activity, increased overall proliferative potential,
and reduced secretion of pro-inflammatory cytokines.
Nevertheless, the transduced cultures eventually do reach
senescence, which is associated with increased CTLA-4
gene expression and a loss of CD28 cell surface expression.
These findings further elucidate the central role of CD28 in
the replicative senescence program, and may ultimately
lead to novel therapies for diseases associated with
replicative senescence.
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Introduction
The CD28 costimulatory receptor, a 44 kDa membrane
glycoprotein expressed on nearly all human T lymphocytes
at birth, provides the requisite secondary signal for
initiation of an immune response [1]. Binding of CD28 to
its CD80 ligands on antigen-presenting cells transduces
survival and proliferation signals, as well as induction of
interleukin (IL)-2, activation of telomerase, stabilization of
mRNA for several cytokines, increased glucose metabo-
lism, and enhanced T cell migration and homing [2–7].
During aging, there is an accumulation of T lymphocytes
that lack CD28 expression, particularly within the CD8
subset [8]. Increased proportions of CD8+CD28− T
lymphocytes correlates with multiple negative clinical
outcomes, including decreased vaccine responsiveness,
reduction in the overall T cell repertoire, and diminished
control over infection [9–11]. Cells with this phenotype
have also been observed in younger individuals with HIV/
AIDS, anklylosing spondylitis, and rheumatoid arthritis
[12–14]. A variety of studies have confirmed that these
CD8+CD28− T lymphocytes are the in vivo correlates of
CD8 T lymphocytes that have undergone multiple rounds
of antigen-driven proliferation in cell culture and have
reached the end-stage of replicative senescence [15].
Our previous studies have shown that modification of
CD28-related pathways prevented or retarded the process of
replicative senescence. For example, constitutive expres-
sion the human telomerase catalytic component (hTERT)
gene in virus-specific CD8 T lymphocytes led to unlimited
proliferation, and enhanced anti-viral effector functions.
[16]. Nevertheless, the loss of CD28 expression, although
significantly retarded, was not prevented. Prolonged
expression of CD28 expression was also documented in
studies on long-term cultures of CD8 T lymphocytes in
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inhibited. The cultures showed significant increases in
telomerase activity, IL-2 gene transcription, and prolifera-
tive potential [17]. Furthermore, the secretion of pro-
inflammatory cytokines was significantly decreased, and
expression of the p21 cell cycle inhibitor expression was
delayed. However, the cultures ultimately did reach
replicative senescence, suggesting that manipulation of
more upstream events in the senescence pathway, such as
CD28 itself, might provide a more robust approach.
CD28 signaling is essential for optimal telomerase
activity. Indeed, the decline in telomerase activity as CD8
T cells progress in culture to replicative senescence
precisely parallels the loss of CD28 expression, and
blocking CD28 signaling abrogates activation-induced
telomerase upregulation [4]. The goal of the current study,
therefore, was to investigate the effect of introducing an
exogenous CD28 gene into cultures of chronically activated
human CD8 T cells. We show that continuous CD28
expression significantly retards the appearance of a
majority of the phenotypic and functional changes
associated with replicative senescence. The ultimate
cessation of proliferation in the transduced cultures,
albeit after a significantly prolonged period of active cell
division, was associated with an increase in CTLA-4
expression, correlating with a loss of CD28 cell surface
expression. These findings further elucidate the central role of
CD28 expression changes in the replicative senescence
program, and may help in the design of novel therapeutic
approaches that target this pathway in clinical situations
associated with chronic immune activation.
Materials and Methods
Cell Cultures Human peripheral blood samples from self-
reported healthy donors under 40 years of age were
acquired by venipuncture after informed consent, and in
accordance with the UCLA IRB. After centrifugation, the
layer of peripheral blood mononuclear cells (PBMC) was
carefully removed and washed twice in “complete RPMI”
(10% fetal bovine serum, 10 mM Hepes, 2 mM glutamine,
50 IU/mL penicillin/streptomycin). The EasySep CD8
enrichment kit (Stemcell) was used to isolate CD8+ T cells
by negative selection, and purity of the cells was verified by
flow cytometry. Cell cultures were established as described
previously [18]. Briefly, CD8 T cells were exposed to T cell
activation microbeads (anti-CD2/3/28, Miltenyi) with 10 μl
microbead cocktail added for every 1×10
6 cells, and
stimulation repeated every 14 days. Cultures were supple-
mented with recombinant IL-2 (20 U/mL). Every 3–4 days,
viable cell concentration was determined by trypan blue
exclusion, and when the concentration reached ≥8×10
5/ml,
cells were subcultivated to a density of 5×10
5 cells/ml.
Population doublings (PD) were determined according to
the formula:
PD ¼ log2 final cell concentration=initial cell concentration ðÞ
CD28 Gene Transduction The pBABE retroviral super-
natants containing either CD28-puromycin, or empty
vector-puromycin were provided by the UCLA Vectorcore
(Los Angeles, CA). On day 4 following the first stimula-
tion, 1×10
6 CD8 T cells were isolated and the media was
removed by centrifugation. Cells were resuspended in
either CD28 or empty vector viral supernatants, supple-
mented with 8 μg/ml polybrene, and centrifuged at 1,800×g
for 3 h. Cells were incubated in the viral supernatant
overnight, at which point they were washed with complete
RPMI 1640. A second round of transduction was performed
after 24 h to ensure optimal gene transfer. Transduced cells
were selected with pre-titrated concentration of puromycin
(Sigma-Aldrich, St. Louis, MO) for 3 days. Transduction
efficiency ranged from 5% to 15% and gene expression
remained stable for the life of the culture.
Flow Cytometry Surface expression of CD4, CD28, CD8,
and CD3 was examined by immunostaining and flow
cytometry. Cells were incubated with FITC-conjugated
anti-CD4, PE-conjugated anti-CD28, allophycocyanin
(APC)-conjugated anti-CD3, and PerCp-conjugated anti-
CD8 (BD Biosciences, San Jose, CA) at 4°C for 20 min,
washed, and fixed in PBS containing 1% paraformalde-
hyde. Parallel samples were incubated with Ig isotype
control antibody or secondary Abs (BD Biosciences). All
samples were analyzed on a FACS Calibur flow cytometer
(Beckton Dickson). Fluorescence data from at least 25,000
cells were acquired. Analysis of data was performed using
Cell Quest Pro (BD Biosciences).
Real-Time Quantitative Polymerase Chain Reaction RNA
was isolated using the Qiagen RNAeasy kit (Qiagen,
Valencia, CA), and quantified using the Quant-iT Ribo-
green RNA Assay Kit (Molecular Probes). cDNAs were
synthesized with the iScript cDNA synthesis kit (Bio-Rad)
using 500 ng RNA. Real-time quantitative polymerase
chain reaction assays were performed using the iQ SYBER
Green SuperMix and IQCycler (Bio-Rad). GAPDH was
used as an internal control. The sequences were designed
with the aid of Beacon Designer software and synthesized
at Integrated DNA Technologies, Inc.
CTLA-4 sense—TGAGTTGACCTTCCTAGATGATTCC,
anti-sense—CTGGGTTCCGTTGCCTATGC; IL-2 sense—
TCACCAGGATGCTCACATTTAAGTTTTAC, anti-sense—
TTCCTCCAGAGGTTTGAGTTCTTCTTC; interferon
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GAC, anti-sense—GCGTTGGACATTCAAGTCAGTT
ACC; adenosine deaminase (ADA) sense—CAGGCTAAC
TACTCGCTCAACACAG, anti-sense—TGTCCCGTTT
GGTCATCTGGTAATC; GAPDH sense—GGTCATGA
GTCCTTCCACGATACCA, anti-sense—CCTCAAGATC
ATCAGCAATGCCTCCT.
Samples were run in triplicate in a 96-well plate at the
following settings: 95º C for 15 s, 61°C for 30 s, 72°C for
30 s, using single fluorescence measurement.
Cytokine Measurements Culturesupernatantswereharvested
96 h post-stimulation and analyzed for IL-6 and TNF-α in an
ELISA Ready-Set-Go (eBioscience, San Diego, CA). All
measurements were performed in triplicate wells and in
accordance to manufacturer's recommendations.
Telomerase Activity Measurements Telomerase activity was
determined using the telomere repeat amplification protocol
(TRAP), as previously described in Saldanha et al. [19],
with minor modifications.
p21 Quantification p21 concentration was determined
through the use of a p21 quantification assay (Invitrogen,
San Diego, CA). All measurements were performed in
triplicate wells and in accordance to manufacturer's
recommendations.
Statistical Analysis Mean values and standard deviation
were calculated for each time-point. Significance was
established by using a two-tail Student's t test, and a p
value of <0.05 is considered significant.
Results
CD28 Expression Prolongs the Period of Telomerase
Activity
CD28 expression provides the necessary secondary
signal for multiple immune pathways, including the
upregulation of telomerase activity. Previous research
on long-term cultures of CD8 T cells has demonstrated
that by the third and all subsequent stimulations
telomerase activity was undetectable, and the progressive
reduction with each stimulation parallels the decline in
CD28 expression [4]. Moreover, preincubation of the
APC with antibodies to the B7 ligands abolishes telomer-
ase activity, further confirming the importance of CD28
signal transduction. Since gene transduction with hTERT,
which prevented replicative senescence, was nevertheless
not able to ultimately prevent loss of CD28 [16], we
tested the converse situation. Indeed, our data show that
CD28 gene transduction was associated with the mainte-
nance of telomerase activity to at least the 7th round of
stimulation. The telomerase activity of the cultures was
measured 4 days after the 7th stimulation, at which time
the empty vector control cultures, contained <10% CD28+
T cells (Fig. 1). Sustained CD28 expression clearly
resulted in significantly higher levels of telomerase
activity even after multiple rounds of activation, as
compared with the minimal telomerase activity in the
control cultures. This was evident in pairs of cultures
tested from all four donors, with the mean fold increase
over all donor cultures being highly significant (Table 1).
These data are consistent with our previous study showing
that the delayed loss of constitutive CD28 expression, by
inhibiting TNF-α, also led to prolonged telomerase
activity [17].
CD28 Gene Transduction Prevents Senescence-Associated
Functional and Phenotypic Changes
In addition to its importance in telomerase upregulation,
CD28 is essential for stabilization of several cytokine
mRNAs [2]. Cultures of senescent CD8 T cells have been
documented to undergo multiple changes in cytokine
secretion patterns, most notably significant increases in
TNF-α a n dI L - 6[ 20], and concomitant decreases in IFN-γ
a n dI L - 2p r o d u c t i o n[ 21]. IL-2, in particular, is closely
linked to CD28, as the expression of CD28 has been
s h o w nt ob en e c e s s a r yf o rI L-2 signal transduction [22,
23]. Moreover, a report on the short term outcome of
introducing exogenous CD28 into cultures of CD28-
ngative cells showed rescue of IL-2 production over~
3 weeks in cell culture [24]. Given the effect of sustained
CD28 expression on telomerase activity, we hypothesized
that this strategy might also prevent the senescence-
associated changes in cytokine production. We compared
the concentration of both TNF-α a n dI L - 6i nt h es u p e r -
Fig. 1 Sustained CD28 expres-
sion is associated with increased
telomerase activity. On day 4
after the 7th stimulation, lysates
were prepared from CD28-
and empty vector-transduced
cultures. Telomerase activity
for 2,500 cell-equivalents was
analyzed using the TRAP assay,
as described in “Materials and
Methods”. Image of the TRAP
gel from a representative
experiment is shown
800 J Clin Immunol (2010) 30:798–805natants 14 days after stimulation for CD28-transduced (n=
5) and vector-transduced (n=5) cultures at ~18 PD, the
time-point at which the control cultures reached senes-
cence. Whereas TNF-α and IL-6 protein levels were high
late in empty vector culture (17 PD), consistent with our
previous findings [20], the CD28-transduced cultures
showed drastically lower concentrations in both cytokines
(Fig. 2a, b). Conversely, the levels of IFN-γ and IL-2
message were significantly higher in CD28-transduced
cultures as compared with the senescent empty vector
cultures (Fig. 2c, d). We also investigated the effect of
sustained CD28 expression on ADA, which, like CD28 is
a critical component of the immunological synapse [25].
In our previous studies, we showed that both ADA
surface expression and activity were significantly greater
in CD8+CD28+ (vs. CD8+CD28−) T cells, and were lost
as CD8 T lymphocytes approached senescence [26]. We
now extend those observations by comparing CD28-
transduced cultures (n=5) and vector control cultures (n=5)
at ~18 PD, for ADA gene expression. Figure 2e shows that
sustained expression of CD28 is associated with significantly
enhanced ADA expression. Thus, CD28 gene transduction
results in the reversal of multiple changes associated with
replicative senescence.
Continuous CD28 Expression Increases the Proliferative
Potential of CD8 T Cells
With chronic exposure to antigen, human CD8 T cells
undergo a finite number of population doublings, ultimately
reaching the irreversible cell cycle arrest known as
replicative senescence [13]. The signature genetic change
associated with this end-stage of T cell differentiation is the
permanent loss of CD28 expression. Indeed, CD8+CD28−
T cells, whether arising in vitro or in vivo, have shortened
telomeres, no telomerase activity, and are unable to
proliferate [12, 27]. We therefore hypothesized that sus-
tained CD28 expression would extend the proliferative
potential of CD8 T cells. Indeed, our data show that there
was a significant increase (P<0.001) in the proliferative
potential in the CD28-transduced cultures (Fig. 3a). In fact,
we observed an average 2
20-fold greater expansion of the
cells in the cultures that had been transduced with CD28,
and this number is probably an underestimate, since we
abstained from performing cell counts during the period of
drug selection. We noted, however, that following this
extensive expansion, CD28 surface expression precipitously
declined, and the cells stopped dividing. Interestingly, in
contrast to unmanipulated T lymphocyte cultures, where both
CD28protein and geneexpressionare irreversiblysuppressed
at senescence, the CD28-transduced cultures that ceased
dividing lost only the surface CD28 expression, with no
change in gene expression (data not shown). The possibility
that the ultimate growth arrest of the CD28-transduced
cultures was irreversible was verified by the increased
expression of the senescence-associated cell cycle inhibitor,
p21, late in culture (Fig. 3b).
CTLA-4 Increases with Culture Age Correlates with CD28
Cell Surface Expressional Loss
To explore the underlying mechanism for the loss of
CD28 surface expression in the transduced cultures, we
investigated the possible role CTLA-4, which is known
to compete with the CD28 ligands on APC, and is
involved with the down-regulation of immune responses
after T cell activation [28]. Interestingly, elderly persons
show increased proportions of CD8+CD28− regulatory T
cells that express CTLA-4 [29]. Furthermore, persons with
HIV/AIDS, which is considered a model of premature
immunological aging [30], have increased proportions of
CD4+CD28− T cells that express CTLA-4 [31, 32]. To
determine the possible role of CTLA-4 in the CD28-
related changes associated with replicative senescence, we
first evaluated the level of CTLA-4 message in early and
late unmanipulated cultures, which lose CD28 protein and
gene expression with increasing population doublings. In
these cultures, we observed that CTLA-4 transcripts, as
measured by real-time PCR, are significantly increased
with culture age (Fig. 4). A distinctly different scenario
occurred in the CD28-transduced cultures that eventually
ceased dividing after an extensive period of expansion.
I n d e e d ,a l t h o u g ht h e r ew a sa ni n c r e a s ei nC T L A - 4g e n e
expression at the time-point when CD28 surface expres-
sion was lost, this changes was not associated with any
reduction in the message levels of the exogenously
introduced gene (data not shown). Thus, the non-
proliferative state that occurred in the transduced cultures
may be under different regulatory control mechanisms as
compared with unmanipulated CD8 T cell cultures that
reach replicative senescence.
Table I Sustained CD28 expression maintains telomerase activity
Donor Fold increase
CD28/Empty vector
1 2.34
2 1.92
3 2.45
4 1.81
Mean±SD 2.13±0.311
p value 0.00034
Telomerase activity for each donor’s culture was determined as the
fold increase over its respective control (empty vector) at 2,500 cell
equivalents, 4 days after 7th stimulation. The mean fold increase is
given and p value determined compared with control
J Clin Immunol (2010) 30:798–805 801Discussion
The current study provides the first documentation that
introduction of an exogenous CD28 gene into human CD8
T lymphocytes delays the onset of replicative senescence
and the associated genetic and functional changes normally
observed in cell culture. Importantly, telomerase activity,
which is central to the telomere-loss that signals replicative
senescence, is maintained through at least the 7th round of
stimulation, in contrast to the previously documented loss
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Fig. 2 Effect of sustained CD28 expression on senescence-associated
cytokine patterns and ADA expression. Cytokine profiles were
evaluated for CD28-transduced (n=5) and vector-transduced (n=5)
cultures at ~18 PD, the time-point at which the control culture reached
senescence. a and b IL-2 and IFN-γ mRNA levels determined by real-
time quantitative PCR; results expressed relative to GAPDH; c and d
concentrations of IL-6 and TNF-α measured by ELISA. e ADA
mRNA levels determined by real-time quantitative PCR. *P<0.05;
***p<0.001
802 J Clin Immunol (2010) 30:798–805by the 3rd stimulation [4]. Our data also provide new
insights into the role of CTLA-4 in the senescence program.
In the absence of gene transduction, CTLA-4 message
increases with culture age, and in those cultures, both
protein and message of CD28 progressively declines. By
contrast, when the proliferative activity in the CD28-
transduced cultures eventually declines, the increased
CTLA-4 expression is not associated with altered CD28
gene transcription, but rather, correlates only with a loss of
CD28 cell surface expression. These studies, therefore,
suggest that there is a post-translation down-regulation of
CD28 that remains to be elucidated. Further investigation
into CD28 regulation could provide new insights into the
population of CD8+CD28− T cells present in vivo that are
associated with a variety of deleterious health effects in
humans, including reduced influenza vaccine responses,
various forms of cancer [9, 33–35], and more rapid
progression to AIDS [36].
We observed that sustained CD28 expression, via gene
transduction, leads to the long-term maintenance of
telomerase activity. Previous research has shown that
CD28 is essential for optimal telomerase activity, and that,
not only do CD8 T cells lose telomerase in parallel with the
loss of CD28 expression, but also inhibition of the B7
ligands on APC significantly reduces telomerase activity
[4]. Enhanced telomerase activity has been shown to be
essential for the immune control of HIV both in vitro and in
vivo [16]. Here, we show that that telomerase activity of
chronically stimulated CD8 T cells can be maintained by
the continuous expression of exogenous CD28 (Fig 1). The
present study is consistent with our previous reports
showing that sustained telomerase activity, by either gene
transduction or exposure to a chemical telomerase activator,
is associated with significantly enhanced proliferative
potential [16, 37].
In addition to telomerase activity, CD28 signaling is
essential for production of a variety of cytokines. As T cells
approach replicative senescence in culture, not only is
CD28 expression lost, but there is a dramatic alteration in
the profile of various cytokines. Specifically, as CD8 Tcells
approach senescence, they secrete increasing amounts of
both the pro-inflammatory cytokines, TNF-α and IL-6. We
observed that sustained CD28 expression greatly reduces
the secretion of these two cytokines, while increasing
expression of IFN-γ and IL-2 (Fig. 2). These results extend
1.2
Early
***
Late
1 1
0.8
0.6
0.4
 
0.2
C
T
L
A
-
4
 
e
x
p
r
e
s
s
i
o
n
 
o
v
e
r
 
G
A
P
D
H
0 0
1234567 A 1 2 3 4 5 6 7 Average
Fig. 4 CTLA-4 expression increases with culture age. Long-term
CD8 T lymphocyte cultures were established as described in
“Materials and Methods”. On day 4 after stimulation cell pellets from
early (i.e., 10% of in vitro lifespan) and late (i.e., 90% of in vitro
lifespan) were collected for real-time quantitative PCR, in which
CTLA-4 expression was compared with that of GAPDH. ***P<0.001
50
45 ***
40
35
30
P
D
25
20
15
10
Empty vector CD28
250
20 PD
38 PD
200
150
100
50
p
2
1
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
(
p
g
/
m
l
)
0
123 123
ab
Fig. 3 Sustained CD28 increases the proliferative potential of CD8 T
lymphocytes. Long-term CD8 T lymphocyte cultures were established
from PBMC of healthy donors (n=5), as described in the “Materials
and Methods”. After 4 days, CD8 T cells were transduced with either
empty vector or vector containing the CD28 transgene, and population
doublings (PD) followed until replicative senesce was reached. a
Population doublings for both types of cultures are shown, with the
mean PD indicated by the horizontal line, ***P<0.00. b p21
concentration in three representative CD28-transduced cultures at 20
and 38 PD
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when CD28 loss was delayed via TNF-α inhibition [17]. In
that study, it was not possible to differentiate whether the
reduction in IL-6 was due to the direct effect of higher
CD28 expression or to an indirect effect of TNF-α
inhibition. By contrast, the current study shows clearly
show that CD28 is directly involved in the maintenance of a
“more youthful” cytokine secretion pattern.
Our studies also yield additional insights into the
potential role of CTLA-4 in the generation of senescent
CD8 T lymphocytes. Indeed, the data in Fig. 4 provide the
first evidence of an increase in CTLA-4 expression in
human CD8 T lymphocytes as they approach replicative
senescence, suggesting yet another mechanism by which
CD28 is irreversibly down regulated after chronic activa-
tion in vitro. We have previously documented the potential
involvement of TNF-α and adenosine in this down-
regulation; combining those observations with the current
data, we conclude that multiple pathways may contribute to
the generation of CD8+CD28− T lymphocytes in vivo. Our
current demonstration of three concomitant changes—loss
of exogenous CD28 surface expression, upregulation of
CTLA-4message,andthe suddencessationofproliferation—
underscorestheimportanceofthesurfaceexpressionofCD28
protein in delivering proliferation signals. Indeed, despite the
sustained gene expression of CD28, the cells were unable to
enter cell cycle, as verified by an increase in p21 concentra-
tion. While, CD56 expression has been associated with
senescence [38], we and others have shown that cultures of
CD8 T cells that reach replicative sensescence lack CD28
and accumulate p21 and p16 [16, 39]. Future studies will
focus on analysis of the downstream signaling mechanism
associated with the increase in CTLA-4, and its ultimate
repression of CD28 protein expression. In our cultures, we
have not been able to detect CTLA-4 on the cell surface or
intracellularly, possibly reflecting its rapid turnover or
degradation.
In summary, our results further elucidate the central role
of CD28 signaling in chronically activated human CD8 T
lymphocytes. As these cells progress to replicative senes-
cence in culture, CD28 expression is lost, and this loss is
associated with a variety of phenotypic and functional
changes. Our data show that sustained CD28 expression,
via gene transduction, significantly retards many of these
changes. Based on the growth arrest that was ultimately
observed even in the transduced cultures, we conclude that
CTLA-4 provides another possible mechanism that con-
tributes to the irreversible loss of CD28 associated with
senescence. Future studies that test the effects of CTLA-4
inhibition in combination with CD28 gene transduction
should provide additional insights into the complex
regulatory influences on CD8 T cell senescence. Ultimately,
these findings may, therefore, lead to novel therapeutic
approaches to prevent the production of senescent CD8 T
cells in vivo due to aging, cancer, and HIV/AIDS.
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